Crystalline forms of a purine derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8889861
SERIAL NO

13574488

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new crystalline forms of a purine derivative which exhibits excellent anti-tumour activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYCLACEL LIMITEDLONDON EC2Y 5AU

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Atherton, Jonathan Charles Christian Co Durham, GB 3 77
Fernades, Philippe Sunderland, GB 1 75
Northen, Julian Scott South Shields, GB 33 315
Skead, Benjamin Mark Cambridge, GB 8 115
Worrall, Christopher Peter Northwich, GB 4 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 18, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00